Fuente: © Joe Gibbs Racing
http://www.joegibbsracing.com/

NASCAR: JOE GIBBS RACING: Astellas Pharma US, Inc., GlaxoSmithKline, and VESIcare® (solifenacin succinate) Sponsor the #18 Race Car at Chicagoland Speedway to Raise Awareness about Overactive Bladder

Rookie Driver J.J. Yeley to Drive VESIcare Car at USG Sheetrock 400

/noticias.info/ It is estimated that 17 million men and women in the United States, especially those age 50 and older, may have a common yet under-recognized medical condition, called overactive bladder (OAB). To bring attention to the condition, Astellas Pharma US, Inc. (Astellas) and GlaxoSmithKline (GSK) are working together with NASCAR driver JJ. Yeley, who will be driving #18 Joe Gibbs Racing Chevrolet during the July 9 USG Sheetrock 400 NASCAR NEXTEL Cup Series race at Chicagoland Speedway in Joliet.

The sponsorship is part of an ongoing promotional campaign to help raise awareness about OAB and VESIcare® (solifenacin succinate) tablets, a treatment for OAB marketed by Astellas and GSK. The campaign goal for VESIcare is to help make sufferers aware that their condition may be treatable and to encourage a dialogue between patients and health care professionals. The logo for VESIcare will be displayed on the #18 Joe Gibbs Racing Chevrolet driven by J.J. Yeley.

"I'm proud of having Astellas and GlaxoSmithKline as primary sponsors, as well as my role in helping raise awareness about a condition that affects millions of people in the United States," said Yeley, a rookie in the Nextel Cup Series. "It's surprising how many people are impacted by OAB, which may affect many of our race fans. This sponsorship helps communicate the availability of a medicine that can treat this condition."


"Since NASCAR has become such a prominent sport, this sponsorship is a great way to bring important messages about overactive bladder to this large audience," said Stan Hull, senior vice president of U.S. Pharmaceuticals at GSK, which is co-promoting VESIcare with Astellas. "OAB may have a significant impact on a person's quality of life and many people with OAB mistakenly believe the disease cannot be treated, so I commend the entire #18 team for joining us in the effort to help race fans better understand conditions like OAB."


About Overactive Bladder
Overactive bladder affects an estimated 17 million men and women in the United States, yet many mistakenly believe it cannot be treated. For people with OAB, inappropriate signals are sent to the muscles in the bladder causing them to contract before the bladder is full. These bladder contractions may cause strong, sudden urges, and a frequent need to go to the bathroom, sometimes without any advance warning. Many patients cope with their symptoms by restricting fluids, carrying extra clothing, and "mapping" bathroom locations wherever they go. Some patients even curtail their social activities for fear of an embarrassing leaking accident. notas_de_prensa_archivo